- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05344534
Statewide System and Organizational Strategy for EBP Implementation (LOCI-SL)
January 13, 2026 updated by: Gregory Aarons, University of California, San Diego
Statewide System and Organizational Strategy for Evidence-Based Practice Implementation and Sustainment in Substance Use Disorder Treatment
This project will test an implementation strategy that seeks to align system, organization, and clinic leadership strategies to implement and sustain the Lyssn artificial intelligence (AI) quality assurance platform to support implementation of Motivational Interviewing (MI) and evidence-based practice (EBP) for substance use disorders.
The Leadership and Organizational Change for Implementation - System Level (LOCI-SL) strategy seeks to engage policymakers and funders at the system level to improve implementation leadership, climate, provider attitudes and behaviors at the provider organization level to enhance implementation climate for EBP.
LOCI-SL will be tested in a statewide addiction service system through clinics in community based behavioral health organizations.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The NIH has called for testing promising implementation strategies (PAR-19-274) and there is a critical need for implementation and sustainment of effective and evidence-based practices (EBPs) to address health conditions including substance use disorders (SUDs) which are among the most complex of public health issues.
The proposed project is consistent with NIDA's Priority Focus Area "Strategies to improve the effective and sustainable implementation of evidence-based prevention and treatment interventions (implementation science)."
Most implementation strategies do not address the complex multilevel context for implementation in public service sectors, but rather focus on direct service providers.
This proposed project will expand the Leadership and Organizational Change for Implementation (LOCI) organizational change strategy for EBP implementation and sustainment, to address the larger outer system context in which SUD treatment organizations operate through engaging state policy and funding stakeholders along with community-based behavioral health agencies to understand and work toward aligning state-level policies and with organizational implementation improvement strategies.
The project will focus on implementation and sustainment of the Lyssn artificial intelligence (AI) quality assurance platform along with implementation of Motivational Interviewing (MI).
Consistent with the Exploration, Preparation, Implementation, Sustainment (EPIS) framework and system and organizational theory, the investigators will add a system level component to LOCI with the goal of bridging outer and inner context and developing and aligning a positive implementation climate to support implementation and sustainment of Lyssn and MI in SUD treatment agencies.
The study will use mixed qualitative and quantitative methods in a stepped-wedge design to examine change in implementation leadership and implementation climate as a function the LOCI-SL intervention as well as exploring subsequent Lyssn and MI sustainment.
The study will also include a "scaling-out" aim in which data from this study will be used to compare proposed mediational pathways (i.e., mechanisms) with data from a prior study.
The study will involve ongoing engagement with state policy and funding stakeholders and qualitative examination of ways to facilitate academic-policy collaborations to enhance EBP implementation and sustainment.
Study Type
Interventional
Enrollment (Actual)
479
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92093
- UC San Diego
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
- Stakeholders from Oregon Health Authority (OHA), Oregon Alcohol and Drug Policy Commission (ADPC), staff at provider/payer advocacy organizations (e.g., CCO Oregon, Oregon Council for Behavioral Health), and relevant managed care organizations (Coordinated Care Organizations, CCOs), Indiana Department of Mental Health and Addiction (DMHA), or Indiana Department of Child Services (DCS).
- Executives and/or managers at participating substance use disorder and/or mental health treatment agencies.
- Clinic managers/supervisors in clinics that provide substance use disorder and/or mental health treatment.
- Counselors (i.e., service providers) employed at participating agencies that provide substance use disorder and/or mental health treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
assessment only through online survey
|
|
|
Experimental: LOCI
Leadership and Organizational Change for Implementation strategy
|
LOCI is data driven leadership development and coaching for clinic managers and working with agency executives and middle managers to foster a strategic implementation climate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on Implementation Leadership Scale
Time Frame: Change from Baseline through study completion, an average of 9 months
|
Assesses four dimensions of implementation leadership: knowledge, proactive, perseverent, supportive, scale of 0-4 where higher scores are more positive
|
Change from Baseline through study completion, an average of 9 months
|
|
Change on Implementation Climate Scale
Time Frame: Change from Baseline through study completion, an average of 9 months
|
6 dimensions of implementation climate: focus, education, recruitment, selection, recognition, rewards scale of 0-4 where higher scores are more positive
|
Change from Baseline through study completion, an average of 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on Evidence-based Practice Attitudes Scale
Time Frame: Change from Baseline through study completion, an average of 9 months
|
assess individual attitudes toward evidence-based practices scale of 0-4 where higher scores are more positive
|
Change from Baseline through study completion, an average of 9 months
|
|
Change on Implementation Citizenship Behavior Scale
Time Frame: Change from Baseline through study completion, an average of 9 months
|
assesses degree to which provider behaviors support EBP implementation, scale of 0-4 where higher scores are more positive
|
Change from Baseline through study completion, an average of 9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 30, 2021
Primary Completion (Actual)
January 30, 2025
Study Completion (Actual)
January 30, 2025
Study Registration Dates
First Submitted
April 18, 2022
First Submitted That Met QC Criteria
April 22, 2022
First Posted (Actual)
April 25, 2022
Study Record Updates
Last Update Posted (Actual)
January 15, 2026
Last Update Submitted That Met QC Criteria
January 13, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200855
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Experimental
-
University of British ColumbiaOttawa Hospital Research Institute; Government of AlbertaCompleted
-
Philipps University Marburg Medical CenterCompletedControl Group | Experimental Group 1 (Video Personal Expert) | Experimental Group 2 (Video Factual Expert)Germany
-
Peking UniversityPeking University International Hospital; Hebei Medical University Fourth HospitalUnknown
-
University of OttawaRecruiting
-
Universiti Putra MalaysiaEnrolling by invitationExperimental MyastheniaChina
-
Universiti Putra MalaysiaCompletedExperimental MyastheniaChina
-
University of Maryland, College ParkEnrolling by invitationExperimental | Waitlist ControlUnited States
-
Florida State UniversityCompletedExperimental | Placebo ContolUnited States
-
Anwita BiosciencesShanghai Junshi Bioscience Co., Ltd.RecruitingLymphoma | Solid Tumor, Adult | Neoplasm Malignant | Neoplasm, ExperimentalTaiwan
-
Aalborg UniversityRecruitingExperimental Pain in Healthy Human SubjectsDenmark
Clinical Trials on Leadership and Organizational Change for Implementation
-
Jaakko VarpulaRecruitingLeadership | Malnutrition Elderly | Self-HarmFinland
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA); Richmond Behavioral Health Authority...CompletedQuality of Treatment ServicesUnited States
-
Boise State UniversityNational Institute of Mental Health (NIMH); University of Pennsylvania; University... and other collaboratorsCompletedBehavioral Symptoms | ImplementationUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast CancerUnited States, Tanzania
-
University of PittsburghNational Institute of Mental Health (NIMH); University of Michigan; NYU Langone... and other collaboratorsRecruitingAttention Deficit and Disruptive Behavior Disorders | Child Behavior ProblemUnited States
-
Mayo ClinicCompletedAlzheimer Disease | Cognitive Symptom | Pre Senile DementiaUnited States
-
Charles Drew University of Medicine and ScienceNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Palo Alto Veterans Institute for ResearchUnited States Department of DefenseCompletedPosttraumatic Stress DisorderUnited States
-
Kairon Connect, PBCRecruiting
-
Temple UniversityRecruitingOrganizational Partnerships for Healthy Living | Standard of CareUnited States